Rachik Petrosyan: functionalities of the Informational Analytical System allow to expose overrated prices in drug procurement

07-11-2017 | 15:48

Due to disseminated distorted information about performance of the Informational Analytical System for monitoring and control of medicinal drug procurement (IAS), FAS reports: IAS functionalities already enables to estimate average weighted prices for drug procurement per unit of active substance for a particular International Non-Proprietary Name, thanks to which it is possible to expose overrates prices in the course of drug procurement.

Efficiency of reducing budgetary expenses in procurement, and as a consequence, accuracy of the system work to a great extent depends on unifying information in the State Register of Medicinal Drugs.

“Today we can compare average weighted prices per unit of active substance (for INN) with the price for procurement of a particular drug of a specific trade name and dosage, set by the ordering party in the course of drug procurement, and fix overrated prices for particular procurement with regard to the average weighted price. The problem is that to prove overrated prices and incriminate the ordering party, it is necessary to determine the equivalency of the procured drug. Until the Ministry of Health Care does not refine the State Register of Medicinal Drugs, and equivalency is not determined, unfair ordering parties have legal justification of the highest prices fro procured drug from those entered in the Register”, emphasized Deputy Head of FAS Rachik Petrosyan. “Adopting the necessary regulatory acts by the Ministry of Health Care will enable, first, to exclude overrated initial prices in advance and, second, ensure real competition between equivalent medicinal drugs and reduce prices in the course of bidding”.



Site Map

News & Events Press Releases Media Releases Image Library About the FAS Russia What We Do General Information Mission, Goals, Values Priority Setting Institutional Memory Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings GCR Using our website International Cooperation Treaties & Agreements International Working Groups Working Group on Research of Competition Issues in the Market of International Telecommunications (Roaming) Meetings Working Group for Studying Competition Problems in the Pharmaceutical Sector Concept Note Meetings OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 FAS Annual Reports OECD-GVH RCC RCC Newsletter ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 13th session IGE UNCTAD Resolution Russian contributions 14th session IGE UNCTAD Resolution Russian contributions 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD EEU Model Law on Competition ICN BRICS WG (Markets of Social Importance) EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Archive Working Group on Investigating Issues on Pricing in the Oil and Oil Product Markets and Methods of their Functioning Meetings Document Library Legislation Reports & Analytics Cases & decisions Contacts Give feedback Contact us Links Authorities Worldwide